Prof Andrew Roberts
Metcalf Chair in Leukaemia Research
Centre for Cancer Research
555 Scholarly works
5 Projects
HIGHLIGHTS
2025
Research grants (ARC, NHMRC, MRFF)
Enhancing the Activity of BH3 Mimetic Drugs in Blood Cancers
2023
Journal article
Acquired mutations in BAX confer resistance to BH3-mimetic therapy in acute myeloid leukemia
DOI: 10.1182/blood.20220160902022
Journal article
Single-cell multiomics reveal the scale of multilayered adaptations enabling CLL relapse during venetoclax therapy
DOI: 10.1182/blood.20220160402022
Journal article
Enrichment of BTK Leu528Trp mutations in patients with CLL on zanubrutinib: potential for pirtobrutinib cross-resistance
DOI: 10.1182/bloodadvances.20220083252022
Journal article
Clonal hematopoiesis, myeloid disorders and BAX-mutated myelopoiesis in patients receiving venetoclax for CLL
DOI: 10.1182/blood.20210127752020
Research grants (ARC, NHMRC, MRFF)
Exploring the Potential of BH3 Mimetic Anti-Cancer Drugs in Blood Cancers
2017
Research Grant
The International Acute Myeloid Leukaemia Platform Consortium (Iapc)
RECENT SCHOLARLY WORKS
2026
Journal article
The stress-sensing MARCH5 axis governs blood cancer apoptotic resilience via tractable protein-protein interactions.
DOI: 10.1182/blood.20260338742026
Journal article
MAP3K14 (NIK) synonymous variants drive altered splicing to activate NF-κB in mature B-cell malignancies.
DOI: 10.1182/blood.20260342282026
Journal article
Prime editing enables drug-controllable T-cell therapies with clinical immunosuppression.
DOI: 10.1182/blood.20260331562026
Journal article
Long-term outcomes with continuous venetoclax for relapsed chronic lymphocytic leukemia.
DOI: 10.1182/bloodadvances.20260207892026
Journal article
Abstract SY35-01: Enhancing BH3 mimetic drug induced killing of malignant cells for cancer therapy
DOI: 10.1158/1538-7445.am2026-sy35-012026
Journal article
Venetoclax and ibrutinib induces durable clinical responses in marginal zone lymphoma
DOI: 10.1182/bloodadvances.20250166462026
Journal article
Myeloid/lymphoid neoplasms with eosinophilia and ZMYM2::FLT3 fusion: clinical, pathological and molecular clues to a cryptic diagnosis
DOI: 10.1016/j.pathol.2026.02.0092026
Journal article
Blood: flowing stronger than ever after 80 years
DOI: 10.1182/blood.2025032375